advertisement
11.3.3 Apraclonidine, brimonidine (6)
Showing records 1 to 6
Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine
Search within classification 11.3.3 Apraclonidine, brimonidine14914 Ocular hypertension in children treated with brimonidine 0.2%. A clinical study
Montero de Espinosa I; Marquez de Aracena R; Morales C
Archivos de la Sociedad Española de Oftalmologia 2006; 81: 155-159
14566 Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: In glaucoma and ocular hypertension
Frampton JE
Drugs and Aging 2006; 23: 753-761
14717 Brimonidine 0.2% versus brimonidine purite 0.15%: Prophylactic effect on IOP elevation after Nd:YAG laser posterior capsulotomy
Yeom HY; Lee JH; Hong YJ; Seong GJ
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 176-181
14897 Use of antiglaucoma therapy to reduce acute intraocular pressure rise following neodymium: YAG laser iridotomy in angle-closure glaucoma patients
Novak Laus K; Masnec Paskvalin S; Korsic J; Ivekovic R; Zoric Geber M; Mandic Z
Acta Medica Croatica 2006; 60: 113-116
15160 Comparative efficacy of acetazolamide and apraclonidine in the control of intraocular pressure following phacoemulsification
Scuderi G; Regine F; Perdicchi A; Mannino G; Recupero SM
Ophthalmologica 2006; 220: 356-360
14898 Intraocular pressure after ND: YAG laser capsulotomy in pseudophakic patients with glaucoma
Sesar A; Petric I; Sesar I; Lacmnovic Loncar V; Jurisic D; Tomic Z; Mandic Z
Acta Medica Croatica 2006; 60: 109-112
